Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Oral Drug Therapy of Male Sexual Dysfunction: A Guide to Clinical Management extensively reviews the physiology and pharmacology of male sexual dysfunction. In addition, it outlines current pharmacologic strategies in the management of erectile dysfunction as well as rapid ejaculation, and previews the next generation of phosphodiesterase inhibitors that are now pending final FDA review. Other areas of interest include the special risk factors that lead to ED and often impede or complicate its treatment, and the distinguishing of facts versus marketing of nutrition supplements in the management of ED.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Oral Drug Therapy of Male Sexual Dysfunction: A Guide to Clinical Management extensively reviews the physiology and pharmacology of male sexual dysfunction. In addition, it outlines current pharmacologic strategies in the management of erectile dysfunction as well as rapid ejaculation, and previews the next generation of phosphodiesterase inhibitors that are now pending final FDA review. Other areas of interest include the special risk factors that lead to ED and often impede or complicate its treatment, and the distinguishing of facts versus marketing of nutrition supplements in the management of ED.